Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia.

Richards JS, Stanisic DI, Fowkes FJ, Tavul L, Dabod E, Thompson JK, Kumar S, Chitnis CE, Narum DL, Michon P, Siba PM, Cowman AF, Mueller I, Beeson JG.

Clin Infect Dis. 2010 Oct 15;51(8):e50-60. doi: 10.1086/656413.

2.

Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.

Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.

Infect Immun. 2009 Mar;77(3):1165-74. doi: 10.1128/IAI.01129-08. Epub 2009 Jan 12.

3.

The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.

Reiling L, Richards JS, Fowkes FJ, Wilson DW, Chokejindachai W, Barry AE, Tham WH, Stubbs J, Langer C, Donelson J, Michon P, Tavul L, Crabb BS, Siba PM, Cowman AF, Mueller I, Beeson JG.

PLoS One. 2012;7(9):e45253. doi: 10.1371/journal.pone.0045253. Epub 2012 Sep 20.

4.

Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria.

Reiling L, Richards JS, Fowkes FJ, Barry AE, Triglia T, Chokejindachai W, Michon P, Tavul L, Siba PM, Cowman AF, Mueller I, Beeson JG.

J Immunol. 2010 Nov 15;185(10):6157-67. doi: 10.4049/jimmunol.1001555. Epub 2010 Oct 20.

5.

Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.

Cole-Tobian JL, Michon P, Biasor M, Richards JS, Beeson JG, Mueller I, King CL.

Infect Immun. 2009 Sep;77(9):4009-17. doi: 10.1128/IAI.00158-09. Epub 2009 Jun 29.

6.

Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria.

Metzger WG, Okenu DM, Cavanagh DR, Robinson JV, Bojang KA, Weiss HA, McBride JS, Greenwood BM, Conway DJ.

Parasite Immunol. 2003 Jun;25(6):307-12.

PMID:
14507328
7.
8.
9.

Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.

King CL, Michon P, Shakri AR, Marcotty A, Stanisic D, Zimmerman PA, Cole-Tobian JL, Mueller I, Chitnis CE.

Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8363-8. doi: 10.1073/pnas.0800371105. Epub 2008 Jun 3.

10.

Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers.

Krause DR, Gatton ML, Frankland S, Eisen DP, Good MF, Tilley L, Cheng Q.

Infect Immun. 2007 Dec;75(12):5967-73. Epub 2007 Oct 8.

12.

Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.

John CC, Moormann AM, Pregibon DC, Sumba PO, McHugh MM, Narum DL, Lanar DE, Schluchter MD, Kazura JW.

Am J Trop Med Hyg. 2005 Jul;73(1):222-8.

13.
14.

Antibodies and Plasmodium falciparum merozoites.

Ramasamy R, Ramasamy M, Yasawardena S.

Trends Parasitol. 2001 Apr;17(4):194-7. Review.

PMID:
11282510
15.

Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.

Stanisic DI, Fowkes FJ, Koinari M, Javati S, Lin E, Kiniboro B, Richards JS, Robinson LJ, Schofield L, Kazura JW, King CL, Zimmerman P, Felger I, Siba PM, Mueller I, Beeson JG.

Infect Immun. 2015 Feb;83(2):646-60. doi: 10.1128/IAI.02398-14. Epub 2014 Nov 24.

16.

Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum.

Okenu DM, Riley EM, Bickle QD, Agomo PU, Barbosa A, Daugherty JR, Lanar DE, Conway DJ.

Infect Immun. 2000 Oct;68(10):5559-66.

17.
18.

Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.

Persson KE, McCallum FJ, Reiling L, Lister NA, Stubbs J, Cowman AF, Marsh K, Beeson JG.

J Clin Invest. 2008 Jan;118(1):342-51.

19.

Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians.

Scopel KK, da Silva-Nunes M, Malafronte RS, Braga EM, Ferreira MU.

Am J Trop Med Hyg. 2007 Jun;76(6):1084-91.

20.

Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria.

Dodoo D, Theisen M, Kurtzhals JA, Akanmori BD, Koram KA, Jepsen S, Nkrumah FK, Theander TG, Hviid L.

J Infect Dis. 2000 Mar;181(3):1202-5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk